Ciprofloxacin Plus Fluocinolone More Effective for Peds AOMT

Share this content:
Ciprofloxacin Plus Fluocinolone More Effective for Peds AOMT
Ciprofloxacin Plus Fluocinolone More Effective for Peds AOMT

WEDNESDAY, Dec. 28, 2016 (HealthDay News) -- For children with acute otitis media with tympanostomy tubes (AOMT), ciprofloxacin plus fluocinolone is more effective than ciprofloxacin or fluocinolone alone, according to a study published online Dec. 22 in JAMA Otolaryngology-Head & Neck Surgery.

Zorik Spektor, M.D., from the Center for Pediatric ENT-Head and Neck Surgery in Boynton Beach, Fla., and colleagues examined the efficacy and safety of topical ciprofloxacin plus fluocinolone acetonide otic solution relative to cipfloxacin otic solution alone and fluocinolone acetonide otic solution alone for AOMT treatment. Data were included for two twin multicenter randomized trials. The study population included 662 children with AOMT in at least one ear who were randomized to ciprofloxacin plus fluocinolone (223 children), ciprofloxacin alone (221 children), or fluocinolone alone (218 children) for seven days.

The researchers found that the median time to cessation of otorrhea was 4.23 days in patients receiving ciprofloxacin plus fluocinolone, 6.95 days in those receiving ciprofloxacin alone, and not estimable in those receiving fluocinolone alone (P < 0.001). At the test-of-cure visit, the clinical cure rate was 80.6, 67.4, and 47.6 percent, respectively, in the ciprofloxacin plus fluocinolone, ciprofloxacin, and fluocinolone groups, respectively. The corresponding sustained microbiological cure rates were 79.7, 67.7, and 37.6 percent.

"The combination of ciprofloxacin plus fluocinolone is more effective than treatment with ciprofloxacin or fluocinolone alone for AOMT, and it is safe and well tolerated in children," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Laboratorios SALVAT SA, which sponsored the clinical trials as part of the U.S. Food and Drug Administration approval of ciprofloxacin plus fluocinolone combination for treatment of AOMT.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »